openPR Logo
Press release

Automated Cell Culture Systems Market to Reach USD 47.1 Billion by 2036 as Biologics and Cell Therapy Manufacturing Accelerates

06-03-2026 09:36 AM CET | Health & Medicine

Press release from: Future Market Insights Inc

Automated Cell Culture Systems Market

Automated Cell Culture Systems Market

The automated cell culture systems market is experiencing robust growth as biopharmaceutical manufacturers increasingly adopt robotic and software-driven platforms to improve cell culture consistency, reduce contamination risks, and enhance production efficiency, according to latest insights by Future Market Insights. Growing demand for biologics, regenerative medicine, and cell therapy production is driving investments in automated culture workflows across research and commercial manufacturing environments.

Get detailed market forecasts, competitive benchmarking, and pricing trends:
https://www.futuremarketinsights.com/reports/sample/rep-gb-7860

Quick Stats Snapshot

• Market Size (2026): USD 19.7 billion
• Forecast Value (2036): USD 47.1 billion
• CAGR (2026-2036): 9.1%
• Incremental Opportunity: USD 27.4 billion
• Leading Automation Segment: Fully Automated Systems
• Leading Cell Culture Type: Infinite Cell Lines
• Fastest Growing Country: Japan (10.6% CAGR)

Market Size and Forecast: Automation Becomes Essential for Cell Manufacturing

The automated cell culture systems market is projected to grow from USD 19.7 billion in 2026 to USD 47.1 billion by 2036, registering a CAGR of 9.1% during the forecast period.

The increasing complexity of biologics production, expansion of cell therapy pipelines, and rising regulatory focus on traceability and contamination control are accelerating adoption. Automated systems are helping organizations standardize culture workflows while improving scalability and compliance.

Key Growth Drivers: Robotics, Traceability, and Cell Therapy Expansion

1. Growing Cell Therapy Manufacturing
Cell therapy developers require closed, controlled environments to maintain sterility and ensure reproducible outcomes.

2. Increasing Demand for Biologics
Biopharmaceutical companies are automating culture workflows to support large-scale biologics production and improve process consistency.

3. Regulatory Focus on GMP Compliance
Software-enabled platforms that provide complete audit trails and process documentation are gaining traction.

4. Advancements in Robotic Culture Systems
Modern process robots, automated bioreactors, and sensor-integrated platforms improve productivity while reducing labor-intensive operations.

Market Challenges: Cost and Implementation Complexity

Despite strong growth prospects, industry participants face several challenges:

• High capital investment requirements
• Validation and integration complexities
• Limited adoption among smaller laboratories
• Need for skilled technical personnel
• Ongoing maintenance and software management costs

These factors are encouraging vendors to develop modular and scalable automation solutions.

Speak to Analyst: Customize insights for your business strategy:
https://www.futuremarketinsights.com/customization-available/rep-gb-7860

Segmentation Insights: Fully Automated Systems and Infinite Cell Lines Lead Demand

By Automation Level

• Fully Automated Systems are expected to account for 62.0% market share in 2026 due to reduced contamination risk and improved workflow efficiency
• Semi-Automated Systems continue to serve cost-sensitive facilities
• Modular Systems are gaining adoption for phased automation deployment

By Application

• Cell Therapy leads with an estimated 36.0% share in 2026 due to increasing clinical and commercial manufacturing activity
• Drug Discovery remains a key application area for high-throughput screening and research automation

Regional Analysis: Japan and China Drive Global Growth

High-growth countries include:

• Japan (10.6% CAGR): Strong iPSC research and regenerative medicine investments support market expansion
• China (9.4% CAGR): Rapid biologics manufacturing growth and GMP infrastructure development boost adoption
• South Korea (8.8% CAGR): Expanding biomanufacturing clusters increase demand for automated platforms
• France (8.5% CAGR): Government-supported bioproduction initiatives drive implementation

Meanwhile, the United Kingdom (8.2%), Germany (7.3%), and the United States (6.8%) continue to generate stable demand through advanced biopharmaceutical and therapy development ecosystems.

Full Report for Detailed Insights:
https://www.futuremarketinsights.com/reports/automated-cell-culture-systems-market

Competitive Landscape: Innovation and Validation Support Define Leadership

The automated cell culture systems market remains highly competitive, with manufacturers focusing on robotics integration, closed-system workflows, digital monitoring, and validation services.

Key players include:

• Thermo Fisher Scientific
• Sartorius AG
• Lonza Group Ltd
• Merck KGaA
• Corning Incorporated

Recent innovations include Thermo Fisher Scientific's launch of the Gibco CHOvantage GS Cell Line Development Kit and Lonza's FDA-recognized Cocoon Platform, highlighting the industry's focus on advanced manufacturing technologies.

Explore In-Depth Healthcare Market Insights:
https://www.futuremarketinsights.com/industry-analysis/healthcare

Future Outlook: Digital and Closed-Loop Cell Culture Systems Will Transform Production

Over the next decade, automated cell culture systems are expected to evolve from laboratory support tools into critical production infrastructure. Rising demand for biologics, cell therapies, and regenerative medicine products will accelerate investment in robotics, AI-enabled monitoring, and sensor-driven process control technologies.

Organizations that deliver validated, scalable, and fully traceable culture platforms will be well-positioned to capitalize on emerging opportunities through 2036.

Explore Industry Insights:
https://www.futuremarketinsights.com/industry-analysis

Executive Takeaways

• The market is projected to reach USD 47.1 billion by 2036
• Fully Automated Systems will account for 62.0% share in 2026
• Infinite Cell Lines are expected to hold 58.0% market share
• Cell Therapy remains the leading application segment
• Japan is forecast to register the fastest growth at 10.6% CAGR
• The market will create an incremental opportunity of USD 27.4 billion between 2026 and 2036
• Closed-system automation and digital traceability remain major competitive advantages

Explore More Related Studies Published by FMI Research:

Zirconia Based Dental Ceramics Market https://www.futuremarketinsights.com/reports/zirconia-based-dental-ceramics-market

Disposable Medical Gowns Market https://www.futuremarketinsights.com/reports/disposable-medical-gowns-market

CF-PEEK for Medical Market https://www.futuremarketinsights.com/reports/cf-peek-for-medical-market

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com

About Future Market Insights (FMI)

Future Market Insights, Inc. is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization trusted by Fortune 500 companies. With a global presence across the U.S., UK, India, and Dubai, FMI delivers data-driven insights across 30+ industries and 1200 markets worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Automated Cell Culture Systems Market to Reach USD 47.1 Billion by 2036 as Biologics and Cell Therapy Manufacturing Accelerates here

News-ID: 4536269 • Views:

More Releases from Future Market Insights Inc

Lacrimal Devices Market to Reach USD 60.4 Million by 2036 as Dry Eye and Tear Drainage Treatment Demand Accelerates Worldwide
Lacrimal Devices Market to Reach USD 60.4 Million by 2036 as Dry Eye and Tear Dr …
The lacrimal devices market is experiencing steady expansion as increasing diagnosis of dry eye syndrome, growing adoption of minimally invasive ophthalmic procedures, and rising demand for advanced tear drainage management solutions continue to support industry growth, according to latest insights by Future Market Insights. Growing utilization of punctal plugs, lacrimal stents, and intubation tubes across ophthalmic clinics and specialty eye hospitals is creating significant opportunities for manufacturers globally. Get detailed market
Mammalian Transient Protein Expression Market to Reach USD 1,449.4 Million by 2036 as Biologics Research and Antibody Discovery Accelerate Globally
Mammalian Transient Protein Expression Market to Reach USD 1,449.4 Million by 20 …
The mammalian transient protein expression market is experiencing steady expansion as demand for rapid protein production, antibody screening, and recombinant protein research continues to rise across the biopharmaceutical industry, according to latest insights by Future Market Insights. Growing adoption of transient expression platforms for biologics development, vaccine research, and functional assays is creating substantial opportunities for suppliers of vectors, reagents, host cells, and expression systems worldwide. Get detailed market forecasts, competitive
Dental Implantology Software Market to Reach USD 423.0 Million by 2036 as Digital Dentistry Adoption Accelerates Worldwide
Dental Implantology Software Market to Reach USD 423.0 Million by 2036 as Digita …
The dental implantology software market is witnessing steady expansion as dental practices increasingly adopt digital workflows, cloud-based planning platforms, and advanced imaging technologies to improve implant treatment outcomes, according to latest insights by Future Market Insights. Rising utilization of CBCT imaging, growing demand for guided surgery planning, and increasing collaboration between dental clinics and laboratories are creating significant growth opportunities for software providers worldwide. Get detailed market forecasts, competitive benchmarking, and
CRISPR and Cas Gene Market to Reach USD 47.73 Million by 2036 as Gene-Editing Therapeutics Gain Commercial Momentum
CRISPR and Cas Gene Market to Reach USD 47.73 Million by 2036 as Gene-Editing Th …
The CRISPR and Cas gene market is experiencing remarkable growth as regulatory approvals, expanding biotechnology research, and advancements in next-generation gene-editing platforms accelerate global adoption, according to latest insights by Future Market Insights. Growing demand for CRISPR-based therapeutics, research tools, and precision genome engineering technologies is creating substantial opportunities for market participants across the healthcare and biotechnology ecosystem. Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-16325 Quick Stats Snapshot • Market Size

All 5 Releases


More Releases for Cell

Cell Sorting Market Accelerates as Cell Therapy, Immuno-Oncology & Single-Cell R …
The rising focus on precision medicine, immunotherapy, and advanced cell-based research is driving the global cell sorting market into a high-growth phase. With expanding applications in stem cell therapy, CAR-T manufacturing, cancer immunology, and single-cell genomics, demand for accurate, high-purity cell isolation systems is stronger than ever. This release highlights key market trends, segmentation insights, technological innovations, and the factors shaping the future of cell sorting. Download Full PDF Sample Copy
Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic "Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic. Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445 Current
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939 This latest report researches the industry structure, sales, revenue,
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports. This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer. Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u Top Key Players: - Becton, Dickinson and Company Biospherix EMD Millipore Eppendorf AG Merck KGaA Sartorius AG VWR International Cell culture is a rapidly emerging